Главная
Study mode:
on
1
Introduction
2
Methodology
3
Pharmaceutical Companies
4
Traditional vs NonTraditional
5
Traditional Antibiotics
6
Are we moving forward
7
Controversy
8
Betalactamases
9
Nontraditional antibacterial agents
10
Highlights of the manuscript
11
Thoughts on nontraditionals
12
Microbacteria
13
Conclusion
Description:
Explore a critical review of the antibacterial pipeline in this 42-minute video from the American Society for Microbiology. Delve into the World Health Organization's advisory panel analysis of 'traditional' and 'non-traditional' antibacterial agents and modulators in clinical development as of June 30, 2021. Gain insights into the WHO's role in antimicrobial resistance, examine the current state of antibacterial research, and discuss key highlights from the review. Join host Cesar Arias and distinguished guests Dr. Peter Beyer, Dr. Mark Butler, and Dr. Prabhavathi Fernandes as they dissect this crucial publication, covering topics such as methodology, pharmaceutical companies, traditional vs. non-traditional approaches, beta-lactamases, and the future of antibacterial research. Understand the challenges and controversies surrounding the development of new antibiotics and explore potential solutions for combating antimicrobial resistance.

Critical Review of the Antibacterial Pipeline

American Society for Microbiology
Add to list
0:00 / 0:00